Mark J. Sutherland serves as an External Business Advisor at Crystal Genetics, Inc., where he leverages his extensive background in life sciences and precision medicine to drive strategic initiatives and foster growth in the burgeoning field of liquid biopsy and genetic testing. With a keen...
Mark J. Sutherland serves as an External Business Advisor at Crystal Genetics, Inc., where he leverages his extensive background in life sciences and precision medicine to drive strategic initiatives and foster growth in the burgeoning field of liquid biopsy and genetic testing. With a keen focus on achieving clinical-grade accuracy in mutation and variant detection, Mark plays a pivotal role in guiding the company’s efforts in both Germline and Somatic whole genome sequencing. His expertise in corporate strategy and IP licensing is instrumental in establishing strategic alliances that enhance Crystal Genetics' market position and expand its capabilities in molecular diagnostics.
Throughout his career, Mark has demonstrated a profound understanding of the biopharmaceutical landscape, having held key positions at renowned organizations such as PacBio, Omniome, Complete Genomics, and Bina Technologies. His experience in drug discovery and product marketing equips him with the insights necessary to navigate the complexities of the genomics sector. At Crystal Genetics, he is currently involved in several key projects aimed at refining the company’s genetic testing methodologies, ensuring they meet the highest standards of accuracy and reliability.
Mark’s ability to communicate effectively across diverse stakeholders, from researchers to investors, underscores his role as a thought leader in the industry. His commitment to advancing precision medicine through innovative solutions positions Crystal Genetics at the forefront of the liquid biopsy revolution, ultimately contributing to improved patient outcomes in hereditary cancer and rare disease detection. As the landscape of genetic testing continues to evolve, Mark’s strategic vision and expertise will be crucial in steering the company toward its ambitious goals.
